Hyaluronic Acid Coated Chitosan Nanoparticles Reduced the Immunogenicity of the Formed Protein Corona

被引:0
作者
Abdulaziz Almalik
Hicham Benabdelkamel
Afshan Masood
Ibrahim O. Alanazi
Ibrahim Alradwan
Majed A. Majrashi
Assim A. Alfadda
Waleed M. Alghamdi
Haitham Alrabiah
Nicola Tirelli
Ali H. Alhasan
机构
[1] National Center for Biotechnology,NorthWest Centre for Advanced Drug Delivery (NoWCADD), Division of Pharmacy and Optometry
[2] Life science and Environment Research Institute,undefined
[3] King Abdulaziz City for Science and Technology (KACST),undefined
[4] Proteomics Resource Unit,undefined
[5] Obesity Research Center,undefined
[6] College of Medicine,undefined
[7] King Saud University,undefined
[8] The National Center for Genomic Technology (NCGT),undefined
[9] Life science and Environment Research Institute,undefined
[10] King Abdulaziz City for Science and Technology (KACST),undefined
[11] Department of Pharmaceutical Chemistry,undefined
[12] College of Pharmacy,undefined
[13] King Saud University,undefined
[14] School of Health Sciences,undefined
[15] University of Manchester,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Studying the interactions of nanoparticles (NPs) with serum proteins is necessary for the rational development of nanocarriers. Optimum surface chemistry is a key consideration to modulate the formation of the serum protein corona (PC) and the resultant immune response. We investigated the constituent of the PC formed by hyaluronic acid-coated chitosan NPs (HA-CS NPs). Non-decorated chitosan NPs (CS NPs) and alginate-coated chitosan NPs (Alg-CS NPs) were utilized as controls. Results show that HA surface modifications significantly reduced protein adsorption relative to controls. Gene Ontology analysis demonstrates that HA-CS NPs were the least immunogenic nanocarriers. Indeed, less inflammatory proteins were adsorbed onto HA-CS NPs as opposed to CS and Alg-CS NPs. Interestingly, HA-CS NPs differentially adsorbed two unique anti-inflammatory proteins (ITIH4 and AGP), which were absent from the PC of both controls. On the other hand, CS and Alg-CS NPs selectively adsorbed a proinflammatory protein (Clusterin) that was not found on the surfaces of HA-CS NPs. While further studies are needed to investigate abilities of the PCs of only ITIH4 and AGP to modulate the interaction of NPs with the host immune system, our results suggest that this proof-of-concept could potentially be utilized to reduce the immunogenicity of a wide range of nanomaterials.
引用
收藏
相关论文
共 66 条
  • [1] De Jong WH(2008)Drug delivery and nanoparticles:applications and hazards International journal of nanomedicine 3 133-149
  • [2] Borm PJ(2009)Impact of nanotechnology on drug delivery ACS nano 3 16-20
  • [3] Farokhzad OC(2008)Protein-nanoparticle interactions Nano Today 3 40-47
  • [4] Langer R(2012)Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment Chemical Society Reviews 41 2780-2799
  • [5] Lynch I(2012)Biomolecular coronas provide the biological identity of nanosized materials Nature Nanotechnology 7 779-786
  • [6] Dawson KA(2009)Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Advanced drug delivery reviews 61 428-437
  • [7] Walkey CD(2012)Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A review Progress in Polymer Science 37 1457-1475
  • [8] Chan WCW(2013)Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation Journal of controlled release: official journal of the Controlled Release Society 172 1142-1150
  • [9] Monopoli MP(2011)Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model Macromolecular bioscience 11 1747-1760
  • [10] Aberg C(2013)Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles Biomaterials 34 5369-5380